Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...
2 天
GlobalData on MSNFDA grants orphan drug status to Arbor Biotechnologies’ PH1The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation ...
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a ...
Celltrion launches ADC cancer drug trials in U.S. while planning additional INDs Celltrion accelerates its global drug ...
today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) to initiate a clinical study of the company’s investigational UKidney ...
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...
Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...
3 天
GlobalData on MSNAlys Pharmaceuticals receives regulatory approvals for alopaecia areata drug trialUS-based immuno-dermatology company Alys Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA ...
The University of Chicago will receive up to $130 million in funding over the next 10 years as part of a new drug research ...
Am J Health Syst Pharm. 2006;63(11):1022-1028. Q: How can potential medication errors be minimized when dispensing investigational drugs to better ensure patient safety and improve adherence to ...
United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced that the U.S. Food and Drug Administration ( FDA ) has cleared its Investigational N ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果